by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
BOSTON, Sept. 08, 2016 (GLOBE NEWSWIRE) — Albireo Limited, a clinical-stage company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases...
by GlobeNewsWire | Sep 8, 2016 | Globe Newswire, Tech Stocks, Technology, Technology Stocks
NATICK, Mass., Sept. 08, 2016 (GLOBE NEWSWIRE) — VCANBIO USA Co. Ltd. (VCANBIO USA) and VCANBIO Center for Translational Biotechnology (VCANBIO CTB) today announced that they will host an opening ceremony to celebrate the launch of U.S. operations as...
by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
SAN DIEGO, Sept. 08, 2016 (GLOBE NEWSWIRE) — Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, announced the creation of the company’s scientific advisory...
by GlobeNewsWire | Sep 7, 2016 | Globe Newswire
JUPITER, Fla., Sept. 07, 2016 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on the development and large scale manufacture of low cost, better performing biologic vaccines and drugs at flexible...
by GlobeNewsWire | Sep 6, 2016 | Globe Newswire
– Selinexor Achieves Promising Response Rates in Patients with Multiple Myeloma, Including 20.8% in Quad-Refractory and 20.0% in Penta-Refractory Disease – – Expanding Phase 2b STORM Study to Include Approximately 120 Additional Patients with...